Evidence map›Paper›PMID 31278296›Full record

ArticleScientific reports2019

Human adenovirus species C recombinant virus continuously circulated in China.

Jianfang Yang, Naiying Mao, Chuangye Zhang, Binzhi Ren, Hong Li, Na Li, Jing Chen, Ruifu Zhang, Hong Li, Zhen Zhu and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Jianfang YangShanxi Provincial Center for Disease Control and Prevention, Taiyuan, 030012, People's Republic of China.
Naiying MaoNHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, No.155, Changbai Road, Changping District, Beijing, 102206, People's Republic of China.
Chuangye ZhangShanxi Provincial Center for Disease Control and Prevention, Taiyuan, 030012, People's Republic of China.
Binzhi RenShanxi Provincial Center for Disease Control and Prevention, Taiyuan, 030012, People's Republic of China.
Hong LiShanxi Provincial Center for Disease Control and Prevention, Taiyuan, 030012, People's Republic of China.
Na LiShanxi Provincial Center for Disease Control and Prevention, Taiyuan, 030012, People's Republic of China.
Jing ChenShanxi Provincial Center for Disease Control and Prevention, Taiyuan, 030012, People's Republic of China.
Ruifu ZhangShanxi Provincial Center for Disease Control and Prevention, Taiyuan, 030012, People's Republic of China.
Hong LiNHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, No.155, Changbai Road, Changping District, Beijing, 102206, People's Republic of China.
Zhen ZhuNHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, No.155, Changbai Road, Changping District, Beijing, 102206, People's Republic of China. zhuzhen76@163.com.
Wenbo XuNHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, No.155, Changbai Road, Changping District, Beijing, 102206, People's Republic of China. wenbo_xu1@aliyun.com.
Jiangsu Provincial Center for Disease Control and Prevention · CNNational Institute for Viral Disease Control and Prevention · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To date, at least three lineages (Lineage 1-3) that are related to recombinant human adenovirus species C (HAdV-C) have been identified in China. Among them, Lineage 1 includes two Chinese strains, strain KR699642-CHN-20093 (CBJ11) and strain MF315029-CHN-2013 (BJ09), which were collected in Beijing in 2009 and 2013, respectively. Herein, we performed genomic and bioinformatics analysis of two HAdV-C strains (strain SX-2000-140 and strain SX-2004-327) that were isolated from the feces of two healthy children in Shanxi province of China in 2000 and 2004, respectively. Results revealed that the genomes of both Shanxi strains had the highest homology to two Chinese HAdV-C strains belonging to Lineage 1 and harbored the genetic elements of these two strains, thereby presuming that Lineage1 has been circulated in mainland of China for decades. In addition, though the viruses in Lineage 1 showed slightly different recombinant patterns resulting from the recombinant events among the five types of HAdV-C, all the Lineage 1 viruses shared the highest sequence similarities with the HAdV-2 prototype strain (NC_001405-USA-1953) across the genome, especially in the major capsid genes including hexon, and fiber. These results indicated that Lineage 1 viruses that were associated with recombinants shared a common ancestor that is closely related to the HAdV-2 virus. Our current findings confirmed that frequent recombination among the different HAdV-C types might be an important driving force for the molecular evolution of HAdV-C. Therefore, there is a strong need for further comprehensive and systematic monitoring, detection, and research on HAdV-C.

Indexed as

Recombination, GeneticAdenoviruses, HumanAdenovirus Infections, HumanChinaComputational BiologyEvolution, MolecularGenome, ViralGenomicsHumansMolecular Sequence AnnotationPhylogenySequence Analysis, DNA

Identifiers

PMID31278296
PMCPMC6611784
OpenAlexW2953647988

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.